You are here: Industry Insights > Paediatric

News List

CHMP suggests AstraZeneca and Merck’s selumetinib for paediatric patients pharmaceutical-technology
April 28, 2021
The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended AstraZeneca and Merck’s (MSD) selumetinib for conditional marketing authorisation in the EU for treating children aged three years and ...
FDA approves first gene therapy for paediatric spinal muscular atrophy europeanpharmaceuticalreview
May 30, 2019
The FDA has given approval to AveXis for the first treatment of paediatric spinal muscular atrophy (SMA).
European approval for paediatric cystic fibrosis drug europeanpharmaceuticalreview
January 24, 2019
A paediatric treatment for 2 to 5 year olds has been approved by the European Commission to treat children with the most common form of cystic fibrosis…
Predictions of early responses in paediatric acute lymphoblastic leukaemia europeanpharmaceuticalreview
December 17, 2018
Researchers have identified markers of pediatric acute lymphoblastic leukaemia to predict early relapses by testing levels of nucleotide excision repair…
EU approves Gilenya for paediatric MS pharmatimes
November 30, 2018
European regulators have approved Novartis’ Gilenya for the treatment of children and adolescents from 10 to 17 years old with relapsing-remitting forms of multiple sclerosis (RRMS).
US clears paediatric use of GSK’s Arnuity Ellipta pharmatimes
May 24, 2018
US regulators have issued a green light for the once-daily inhaler as maintenance treatment of asthma in children from as young as five years.
Oral antibiotics may raise risk of kidney stones europeanpharmaceuticalreview
May 15, 2018
Paediatric researchers have found that children and adults treated with some oral antibiotics have a significantly higher risk of developing kidney stones…